Akyso is a biotechnology company that offers treatment solutions for rehabilitation and medication for opioid use disorder.
Akyso has raised $15.0M in total funding. The most recent round was Grant. The last funding was announced in July 2025.
Akyso's investors include National Institute on Drug Abuse (NIDA).
Akyso is headquartered in Salisbury, United States.
Akyso is a biotechnology company that offers treatment solutions for rehabilitation and medication for opioid use disorder.
Akyso is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Akyso — Funding & Investors." VCBacked, July 23, 2025, https://www.vcbacked.co/company/akyso. Accessed August 14, 2026.
VCBacked. (2025). Akyso — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/akyso
{{cite web |title=Akyso — Funding & Investors |url=https://www.vcbacked.co/company/akyso |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated